Foundry 12-Month Momentum Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1MU | MICRON TECHNOLOGY INC | Technology | $958.80B | 14.50% |
2AMD | ADVANCED MICRO DEVICES INC | Technology | $808.39B | 12.23% |
3INTC | INTEL CORP | Technology | $477.67B | 7.22% |
4AMAT | APPLIED MATERIALS INC | Technology | $420.53B | 6.36% |
5CAT | CATERPILLAR INC | Industrials | $405.49B | 6.13% |
6LRCX | LAM RESEARCH CORP | Technology | $391.80B | 5.93% |
7KLAC | KLA CORP | Technology | $277.91B | 4.20% |
8DELL | DELL TECHNOLOGIES INC | Technology | $256.87B | 3.88% |
9SNDK | SANDISK CORP | Technology | $200.63B | 3.03% |
10STX | SEAGATE TECHNOLOGY HOLDINGS PLC | Technology | $176.62B | 2.67% |
11MRVL | MARVELL TECHNOLOGY INC | Technology | $165.06B | 2.50% |
12WDC | WESTERN DIGITAL CORP | Technology | $164.49B | 2.49% |
13GLW | CORNING INC | Technology | $133.06B | 2.01% |
14VRT | VERTIV HOLDINGS CO | Industrials | $111.22B | 1.68% |
15BE | BLOOM ENERGY CORP | Industrials | $61.14B | 0.92% |
16HPE | HEWLETT PACKARD ENTERPRISE CO | Technology | $60.67B | 0.92% |
17FIX | COMFORT SYSTEMS USA INC | Industrials | $58.93B | 0.89% |
18LITE | LUMENTUM HOLDINGS INC | Technology | $57.01B | 0.86% |
19COHR | COHERENT CORP | Technology | $54.31B | 0.82% |
20CIEN | CIENA CORP | Technology | $53.00B | 0.80% |
21ALAB | ASTERA LABS INC | Technology | $52.04B | 0.79% |
22TER | TERADYNE INC | Technology | $50.46B | 0.76% |
23FLEX | FLEX LTD | Technology | $43.69B | 0.66% |
24RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 0.60% |
25CRDO | CREDO TECHNOLOGY GROUP HOLDING LTD | Technology | $37.80B | 0.57% |
26CNC | CENTENE CORP | Healthcare | $32.81B | 0.50% |
27CRS | CARPENTER TECHNOLOGY CORP | Industrials | $27.71B | 0.42% |
28ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 0.40% |
29ATI | ATI INC | Industrials | $25.41B | 0.38% |
30ROIV | ROIVANT SCIENCES LTD | Healthcare | $24.82B | 0.38% |
31MRNA | MODERNA INC | Healthcare | $24.53B | 0.37% |
32MKSI | MKS INC | Technology | $21.93B | 0.33% |
33ENTG | ENTEGRIS INC | Technology | $21.16B | 0.32% |
34GH | GUARDANT HEALTH INC | Healthcare | $20.67B | 0.31% |
35MTSI | MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC | Technology | $20.40B | 0.31% |
36STRL | STERLING INFRASTRUCTURE INC | Industrials | $19.59B | 0.30% |
37LSCC | LATTICE SEMICONDUCTOR CORP | Technology | $17.16B | 0.26% |
38AMKR | AMKOR TECHNOLOGY INC | Technology | $15.60B | 0.24% |
39SITM | SITIME CORP | Technology | $14.65B | 0.22% |
40ONTO | ONTO INNOVATION INC | Technology | $13.92B | 0.21% |
41TTMI | TTM TECHNOLOGIES INC | Technology | $13.71B | 0.21% |
42BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 0.21% |
43DOCN | DIGITALOCEAN HOLDINGS INC | Technology | $12.41B | 0.19% |
44AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.18% |
45SMTC | SEMTECH CORP | Technology | $11.64B | 0.18% |
46VICR | VICOR CORP | Technology | $10.83B | 0.16% |
47AEIS | ADVANCED ENERGY INDUSTRIES INC | Industrials | $10.80B | 0.16% |
48ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 0.16% |
49KRYS | KRYSTAL BIOTECH INC | Healthcare | $10.46B | 0.16% |
50HUT | HUT 8 CORP | Financial Services | $10.30B | 0.16% |
51GSAT | GLOBALSTAR INC | Communication Services | $10.20B | 0.15% |
52APGE | APOGEE THERAPEUTICS INC | Healthcare | $10.10B | 0.15% |
53CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.15% |
54VSAT | VIASAT INC | Technology | $9.76B | 0.15% |
55HL | HECLA MINING CO | Basic Materials | $9.61B | 0.15% |
56KYMR | KYMERA THERAPEUTICS INC | Healthcare | $9.52B | 0.14% |
57PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $9.06B | 0.14% |
58WULF | TERAWULF INC | Financial Services | $9.00B | 0.14% |
59VIAV | VIAVI SOLUTIONS INC | Technology | $8.93B | 0.13% |
60PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | $8.77B | 0.13% |
61SYRE | SPYRE THERAPEUTICS INC | Healthcare | $8.70B | 0.13% |
62POWL | POWELL INDUSTRIES INC | Industrials | $8.48B | 0.13% |
63IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 0.13% |
64FORM | FORMFACTOR INC | Technology | $8.23B | 0.12% |
65AAOI | APPLIED OPTOELECTRONICS INC | Technology | $8.22B | 0.12% |
66IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 0.12% |
67PL | PLANET LABS PBC | Industrials | $8.01B | 0.12% |
68AGX | ARGAN INC | Industrials | $7.73B | 0.12% |
69APLD | APPLIED DIGITAL CORP | Financial Services | $7.37B | 0.11% |
70PACS | PACS GROUP INC | Healthcare | $7.30B | 0.11% |
71MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | $7.25B | 0.11% |
72CIFR | CIPHER DIGITAL INC | Financial Services | $7.18B | 0.11% |
73ENS | ENERSYS | Industrials | $7.18B | 0.11% |
74LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.11% |
75ECG | EVERUS CONSTRUCTION GROUP INC | Consumer Cyclical | $6.80B | 0.10% |
76PLXS | PLEXUS CORP | Technology | $6.71B | 0.10% |
77COGT | COGENT BIOSCIENCES INC | Healthcare | $6.68B | 0.10% |
78VSXY | VICTORIA'S SECRET & CO | Consumer Cyclical | $6.47B | 0.10% |
79MXL | MAXLINEAR INC | Technology | $6.43B | 0.10% |
80CGON | CG ONCOLOGY INC | Healthcare | $6.34B | 0.10% |
81MYRG | MYR GROUP INC | Industrials | $6.10B | 0.09% |
82LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.08B | 0.09% |
83ERAS | ERASCA INC | Healthcare | $5.96B | 0.09% |
84GTX | GARRETT MOTION INC | Consumer Cyclical | $5.95B | 0.09% |
85TWST | TWIST BIOSCIENCE CORP | Healthcare | $5.84B | 0.09% |
86KGS | KODIAK GAS SERVICES INC | Energy | $5.79B | 0.09% |
87ENVA | ENOVA INTERNATIONAL INC | Financial Services | $5.79B | 0.09% |
88DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | $5.77B | 0.09% |
89MRCY | MERCURY SYSTEMS INC | Industrials | $5.77B | 0.09% |
90ORKA | ORUKA THERAPEUTICS INC | Healthcare | $5.59B | 0.08% |
91ACMR | ACM RESEARCH INC | Technology | $5.56B | 0.08% |
92TXG | 10X GENOMICS INC | Healthcare | $5.55B | 0.08% |
93SSRM | SSR MINING INC | Basic Materials | $5.31B | 0.08% |
94TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.08% |
95XMTR | XOMETRY INC | Industrials | $5.18B | 0.08% |
96VSH | VISHAY INTERTECHNOLOGY INC | Technology | $5.15B | 0.08% |
97SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $5.10B | 0.08% |
98MTRN | MATERION CORP | Basic Materials | $5.10B | 0.08% |
99KLIC | KULICKE & SOFFA INDUSTRIES INC | Technology | $5.09B | 0.08% |
100IRDM | IRIDIUM COMMUNICATIONS INC | Communication Services | $4.94B | 0.07% |
101DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.07% |
102VCYT | VERACYTE INC | Healthcare | $4.72B | 0.07% |
103LFST | LIFESTANCE HEALTH GROUP INC | Healthcare | $4.49B | 0.07% |
104SEI | SOLARIS ENERGY INFRASTRUCTURE INC | Energy | $4.43B | 0.07% |
105CELC | CELCUITY INC | Healthcare | $4.31B | 0.07% |
106EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | $4.28B | 0.06% |
107ACLS | AXCELIS TECHNOLOGIES INC | Technology | $4.19B | 0.06% |
108UCTT | ULTRA CLEAN HOLDINGS INC | Technology | $4.14B | 0.06% |
109TNGX | TANGO THERAPEUTICS INC | Healthcare | $4.13B | 0.06% |
110LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.06% |
111DYN | DYNE THERAPEUTICS INC | Healthcare | $3.92B | 0.06% |
112LASR | NLIGHT INC | Technology | $3.91B | 0.06% |
113DK | DELEK US HOLDINGS INC | Energy | $3.88B | 0.06% |
114RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.06% |
115CLMT | CALUMET INC | Energy | $3.73B | 0.06% |
116ALMS | ALUMIS INC | Healthcare | $3.65B | 0.06% |
117NHC | NATIONAL HEALTHCARE CORP | Healthcare | $3.56B | 0.05% |
118GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | $3.45B | 0.05% |
119RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.05% |
120SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.05% |
121FSLY | FASTLY INC | Technology | $3.24B | 0.05% |
122ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | $3.24B | 0.05% |
123ONDS | ONDAS INC | Technology | $3.23B | 0.05% |
124VECO | VEECO INSTRUMENTS INC | Technology | $3.19B | 0.05% |
125PENG | PENGUIN SOLUTIONS INC | Technology | $3.10B | 0.05% |
126AXTI | AXT INC | Technology | $3.00B | 0.05% |
127MBX | MBX BIOSCIENCES INC | Healthcare | $2.99B | 0.05% |
128BELFA | BEL FUSE INC | Technology | $2.91B | 0.04% |
129ICHR | ICHOR HOLDINGS LTD | Technology | $2.88B | 0.04% |
130BHE | BENCHMARK ELECTRONICS INC | Technology | $2.81B | 0.04% |
131ADEA | ADEIA INC | Technology | $2.80B | 0.04% |
132VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.04% |
133TRVI | TREVI THERAPEUTICS INC | Healthcare | $2.71B | 0.04% |
134HLIO | HELIOS TECHNOLOGIES INC | Industrials | $2.68B | 0.04% |
135NVTS | NAVITAS SEMICONDUCTOR CORP | Technology | $2.68B | 0.04% |
136KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.04% |
137FLNC | FLUENCE ENERGY INC | Utilities | $2.59B | 0.04% |
138KALU | KAISER ALUMINUM CORP | Basic Materials | $2.58B | 0.04% |
139AEHR | AEHR TEST SYSTEMS | Technology | $2.55B | 0.04% |
140QURE | UNIQURE NV | Healthcare | $2.54B | 0.04% |
141SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.04% |
142COHU | COHU INC | Technology | $2.41B | 0.04% |
143ATRO | ASTRONICS CORP | Industrials | $2.41B | 0.04% |
144DGII | DIGI INTERNATIONAL INC | Technology | $2.41B | 0.04% |
145ROG | ROGERS CORP | Technology | $2.36B | 0.04% |
146OUST | OUSTER INC | Technology | $2.36B | 0.04% |
147NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.31B | 0.03% |
148BAND | BANDWIDTH INC | Technology | $2.30B | 0.03% |
149PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.26B | 0.03% |
150SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.03% |
151DHC | DIVERSIFIED HEALTHCARE TRUST | Real Estate | $2.22B | 0.03% |
152VSTS | VESTIS CORP | Industrials | $2.18B | 0.03% |
153AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.03% |
154AXGN | AXOGEN INC | Healthcare | $2.12B | 0.03% |
155GRC | GORMAN RUPP CO | Industrials | $2.11B | 0.03% |
156GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | $2.07B | 0.03% |
157CDNA | CAREDX INC | Healthcare | $2.05B | 0.03% |
158PDFS | PDF SOLUTIONS INC | Technology | $2.04B | 0.03% |
159RAPP | RAPPORT THERAPEUTICS INC | Healthcare | $2.04B | 0.03% |
160NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.03% |
161EZPW | EZCORP INC | Financial Services | $1.97B | 0.03% |
162AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.03% |
163ECPG | ENCORE CAPITAL GROUP INC | Financial Services | $1.96B | 0.03% |
164ATEX | ANTERIX INC | Communication Services | $1.96B | 0.03% |
165DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.03% |
166TYRA | TYRA BIOSCIENCES INC | Healthcare | $1.91B | 0.03% |
167NEO | NEOGENOMICS INC | Healthcare | $1.90B | 0.03% |
168NGL | NGL ENERGY PARTNERS LP | Energy | $1.89B | 0.03% |
169MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $1.87B | 0.03% |
170ALGT | ALLEGIANT TRAVEL CO | Industrials | $1.86B | 0.03% |
171BCAX | BICARA THERAPEUTICS INC | Healthcare | $1.82B | 0.03% |
172LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Industrials | $1.81B | 0.03% |
173STOK | STOKE THERAPEUTICS INC | Healthcare | $1.81B | 0.03% |
174HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.74B | 0.03% |
175BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.03% |
176TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.03% |
177ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.03% |
178FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.03% |
179CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.03% |
180TH | TARGET HOSPITALITY CORP | Industrials | $1.64B | 0.02% |
181TE | T1 ENERGY INC | Industrials | $1.63B | 0.02% |
182PSNL | PERSONALIS INC | Healthcare | $1.61B | 0.02% |
183PLPC | PREFORMED LINE PRODUCTS CO | Industrials | $1.60B | 0.02% |
184PUMP | PROPETRO HOLDING CORP | Energy | $1.59B | 0.02% |
185INNV | INNOVAGE HOLDING CORP | Healthcare | $1.56B | 0.02% |
186SKYT | SKYWATER TECHNOLOGY INC | Technology | $1.54B | 0.02% |
187SEPN | SEPTERNA INC | Healthcare | $1.51B | 0.02% |
188BRUN | BOOST RUN INC | Technology | $1.50B | 0.02% |
189ALNT | ALLIENT INC | Technology | $1.49B | 0.02% |
190AIP | ARTERIS INC | Technology | $1.43B | 0.02% |
191VPG | VISHAY PRECISION GROUP INC | Technology | $1.38B | 0.02% |
192REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.02% |
193BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.02% |
194FBYD | FALCON'S BEYOND GLOBAL INC | Industrials | $1.35B | 0.02% |
195NWPX | NWPX INFRASTRUCTURE INC | Industrials | $1.33B | 0.02% |
196ABSI | ABSCI CORP | Healthcare | $1.29B | 0.02% |
197INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.02% |
198TTI | TETRA TECHNOLOGIES INC | Energy | $1.25B | 0.02% |
199CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | $1.25B | 0.02% |
200FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.02% |
201TDAY | USA TODAY CO INC | Consumer Cyclical | $1.25B | 0.02% |
202NBR | NABORS INDUSTRIES LTD | Energy | $1.24B | 0.02% |
203DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.19B | 0.02% |
204AVNS | AVANOS MEDICAL INC | Healthcare | $1.17B | 0.02% |
205MYE | MYERS INDUSTRIES INC | Consumer Cyclical | $1.17B | 0.02% |
206ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.16B | 0.02% |
207SVRA | SAVARA INC | Healthcare | $1.13B | 0.02% |
208CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | $1.13B | 0.02% |
209RHLD | RESOLUTE HOLDINGS MANAGEMENT INC | Industrials | $1.10B | 0.02% |
210CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $1.09B | 0.02% |
211JBIO | JADE BIOSCIENCES INC | Healthcare | $1.03B | 0.02% |
212AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.02% |
213BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.02% |
214APPS | DIGITAL TURBINE INC | Technology | $1.01B | 0.02% |
215OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | $1.00B | 0.02% |
216EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $984M | 0.01% |
217ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.01% |
218LWLG | LIGHTWAVE LOGIC INC | Basic Materials | $960M | 0.01% |
219ANNX | ANNEXON INC | Healthcare | $950M | 0.01% |
220MOV | MOVADO GROUP INC | Consumer Cyclical | $859M | 0.01% |
221MITK | MITEK SYSTEMS INC | Technology | $857M | 0.01% |
222AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.01% |
223UMAC | UNUSUAL MACHINES INC | Industrials | $809M | 0.01% |
224UAMY | UNITED STATES ANTIMONY CORP | Basic Materials | $809M | 0.01% |
225ACRS | ACLARIS THERAPEUTICS INC | Healthcare | $793M | 0.01% |
226BLZE | BACKBLAZE INC | Technology | $793M | 0.01% |
227DSGN | DESIGN THERAPEUTICS INC | Healthcare | $785M | 0.01% |
228MNPR | MONOPAR THERAPEUTICS | Healthcare | $744M | 0.01% |
229CLYM | CLIMB BIO INC | Healthcare | $727M | 0.01% |
230OMER | OMEROS CORP | Healthcare | $701M | 0.01% |
231LPTH | LIGHTPATH TECHNOLOGIES INC | Technology | $657M | 0.01% |
232FEIM | FREQUENCY ELECTRONICS INC | Technology | $650M | 0.01% |
233TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.01% |
234ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.01% |
235NVRI | ENVIRI CORP | Industrials | $643M | 0.01% |
236MEC | MAYVILLE ENGINEERING COMPANY INC | Industrials | $634M | 0.01% |
237FET | FORUM ENERGY TECHNOLOGIES INC | Energy | $593M | 0.01% |
238STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.01% |
239FDMT | 4D MOLECULAR THERAPEUTICS INC | Healthcare | $575M | 0.01% |
240IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.01% |
241RLMD | RELMADA THERAPEUTICS INC | Healthcare | $550M | 0.01% |
242ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.01% |
243PKOH | PARK OHIO HOLDINGS CORP | Industrials | $544M | 0.01% |
244XMAX | XMAX INC | Consumer Cyclical | $541M | 0.01% |
245CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | $532M | 0.01% |
246MEI | METHODE ELECTRONICS INC | Technology | $532M | 0.01% |
247ORN | ORION GROUP HOLDINGS INC | Industrials | $518M | 0.01% |
248ZURA | ZURA BIO LTD | Healthcare | $518M | 0.01% |
249NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.01% |
250KYTX | KYVERNA THERAPEUTICS INC | Healthcare | $453M | 0.01% |
251ALTO | ALTO INGREDIENTS INC | Basic Materials | $453M | 0.01% |
252PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.01% |
253TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.01% |
254FLXS | FLEXSTEEL INDUSTRIES INC | Consumer Cyclical | $391M | 0.01% |
255STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.01% |
256ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.01% |
257ELMD | ELECTROMED INC | Healthcare | $349M | 0.01% |
258MRAM | EVERSPIN TECHNOLOGIES INC | Technology | $341M | 0.01% |
259MPTI | M-TRON INDUSTRIES INC | Technology | $328M | 0.00% |
260TWIN | TWIN DISC INC | Industrials | $326M | 0.00% |
261VELO | VELO3D INC | Technology | $316M | 0.00% |
262OSS | ONE STOP SYSTEMS INC | Technology | $313M | 0.00% |
263OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.00% |
264SVCO | SILVACO GROUP INC | Technology | $260M | 0.00% |
265QTTB | Q32 BIO INC | Healthcare | $255M | 0.00% |
266SRZN | SURROZEN INC | Healthcare | $255M | 0.00% |
267ASYS | AMTECH SYSTEMS INC | Technology | $242M | 0.00% |
268ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.00% |
269QUIK | QUICKLOGIC CORP | Technology | $237M | 0.00% |
270RDNW | RIDENOW GROUP INC | Consumer Cyclical | $229M | 0.00% |
271ALOT | ASTRONOVA INC | Technology | $222M | 0.00% |
272KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.00% |
273BDSX | BIODESIX INC | Healthcare | $204M | 0.00% |
274FOCL | FOCAL INC | Healthcare | $204M | 0.00% |
275INTT | INTEST CORP | Technology | $169M | 0.00% |
276AMPG | AMPLITECH GROUP INC | Technology | $168M | 0.00% |
277KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.00% |
278AP | AMPCO PITTSBURGH CORP | Industrials | $156M | 0.00% |
279RFIL | R F INDUSTRIES LTD | Industrials | $143M | 0.00% |
280SIF | SIFCO INDUSTRIES INC | Industrials | $141M | 0.00% |
281OCC | OPTICAL CABLE CORP | Technology | $130M | 0.00% |
282VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.00% |
283VATE | INNOVATE CORP | Industrials | $123M | 0.00% |
284SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.00% |
285WYY | WIDEPOINT CORP | Technology | $115M | 0.00% |
286TRT | TRIO-TECH INTERNATIONAL | Technology | $103M | 0.00% |
287CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.00% |
288RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
289INTG | INTERGROUP CORP | Consumer Cyclical | $84M | 0.00% |
290NRXS | NEURAXIS INC | Healthcare | $84M | 0.00% |
291VNCE | VINCE HOLDING CORP | Consumer Cyclical | $83M | 0.00% |
292ROLR | HIGH ROLLER TECHNOLOGIES INC | Consumer Cyclical | $76M | 0.00% |
293BNAI | BRAND ENGAGEMENT NETWORK INC | Technology | $76M | 0.00% |
294BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.00% |
295LONA | LEONABIO INC | Healthcare | $68M | 0.00% |
296EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $6.61T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 84% toward Growth. +2% unclassified (37 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual51.7%Margin-26.7%
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 48.0% | 26.3% |
| 3 yearsp.a. | 36.5% | 21.9% |
| 5 yearsp.a. | 21.2% | 18.8% |
| 10 yearsp.a. | 22.6% | 11.1% |
| Since inceptionp.a. | 15.8% | 10.3% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 34.8% | 40.2% |
| 2025 | 9.2% | -16.7% |
| 2024 | 64.3% | 49.5% |
| 2023 | 30.5% | -19.4% |
| 2022 | -14.1% | 56.4% |
| 2021 | 1.4% | -20.2% |
| 2020 | 59.0% | 21.9% |
| 2019 | 29.8% | -2.0% |
| 2018 | 3.4% | 23.4% |
| 2017 | 26.7% | 13.5% |
| 2016 | 5.4% | -17.6% |
| 2015 | 3.8% | 40.4% |
| 2014 | 14.1% | 4.3% |
| 2013 | 42.5% | -0.4% |
| 2012 | 25.8% | 8.2% |
| 2011 | -7.5% | 19.9% |
| 2010 | 33.1% | 10.7% |
| 2009 | 17.2% | -49.1% |
| 2008 | -39.4% | 41.9% |
| 2007 | 36.3% | 68.4% |
| 2006 | 3.2% | -12.5% |
| 2005 | 22.3% | 25.0% |
| 2004 | 4.8% | -15.0% |
| 2003 | 57.7% | -5.6% |
| 2002 | -14.9% | 41.0% |
| 2001 | -6.0% | -1.1% |
| 2000 | -22.7% | -2.4% |
| 1999 | 124.3% | 103.7% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry 12-Month Momentum Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a 12-Month Momentum signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.